跳至主要内容
临床试验/NCT03079271
NCT03079271Unknown4 期

An Open Label Comparing the Short Term Efficacy of Lacrisert

Virginia Eye Consultants1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
50
试验地点
1
主要终点
Dry eye disease measured by Corneal Staining

研究概览

简要总结

To evaluate the short term effects of LACRISERT®. upon fluorescein corneal staining, tear osmolarity and surface topography in human subjects with dry eye disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Has Dry Eye disease indicated by a staining score of ≥ 4 and Speed score of >6

排除标准

  • •Concurrent involvement in any other clinical trial
  • •Anticipated contact lens wear during the study and 14hours prior to Day -History of corneal transplant
  • •Active ocular infection, uveitis or non-KCS inflammation
  • •History of recurrent herpes keratitis or active disease within the last six months
  • •Topical ophthalmic medications during the study
  • •Temporary collagen punctal plugs within one week prior to study.

研究组 & 干预措施

open label

Other

干预措施: Lacrisert, 5 Mg Ophthalmic Insert (Drug)

结局指标

主要结局

Dry eye disease measured by Corneal Staining

时间窗: 10 days

Dry eye disease measured by topographic results

时间窗: 10 days

Dry Eye disease measured by OSDI questionnaire

时间窗: 10 days

次要结局

未报告次要终点

研究者

发起方
Virginia Eye Consultants
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验